Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. NEOLPHARMA, INC.
FDA Inspection
•NEOLPHARMA, INC.•April 1, 2022

NEOLPHARMA, INC. – FDA Inspection, Apr 1, 2022

Record Details

This FDA Inspection record concerns NEOLPHARMA, INC., with an inspection on April 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
NEOLPHARMA, INC.
Inspection Date
April 1, 2022
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 333f1bda-c222-419f-af7c-dea739c8f225

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1166181
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

1
  1. 21 CFR 211.100(b)SOPs not followed / documented

Full citation text and observation details available on the Dashboard.

Other FDA inspections of NEOLPHARMA, INC.

5
DateClassificationOfficeProject area
March 10, 2026Not classifiedSan Juan District OfficeDrug Quality Assurance
February 5, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 7, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 18, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 7, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for NEOLPHARMA, INC.
  • FDA Inspection 1304150 - 2026-03-10
  • FDA Inspection 1078192 - 2019-02-05
  • FDA Inspection 1018694 - 2017-06-07
  • FDA Inspection 929761 - 2015-06-18
  • FDA Inspection 822275 - 2013-03-07

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore NEOLPHARMA, INC.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.